A prospective randomized trial of the antiemetic efficacy and cost-effectiveness of intravenous and orally disintegrating tablet of ondansetron in children with cancer.


Corapçioglu F., Sarper N.

Pediatric hematology and oncology, vol.22, pp.103-14, 2005 (SCI-Expanded) identifier identifier identifier